Quick Answer
VIEMED HEALTHCARE, INC. reported Total Revenue of $270.28 million for fiscal year 2025.
VIEMED HEALTHCARE, INC. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $270.28M +20.5% |
$224.26M +22.5% |
$183.01M +31.8% |
$138.83M +18.6% |
$117.06M -10.8% |
$131.31M +63.6% |
| Net Income | $14.93M +32.6% |
$11.27M +10.0% |
$10.24M +64.6% |
$6.22M -31.8% |
$9.13M -71.1% |
$31.53M +269.9% |
| Diluted EPS | $0.37 +32.1% |
$0.28 +12.0% |
$0.25 +56.2% |
$0.16 -27.3% |
$0.22 -71.8% |
$0.78 +271.4% |
| Total Assets | $199.15M +12.5% |
$177.07M +14.3% |
$154.90M +32.3% |
$117.04M -0.8% |
$117.96M +4.8% |
$112.56M +91.7% |
| Cash and Equivalents | $13.50M -23.0% |
$17.54M +36.6% |
$12.84M -24.1% |
$16.91M -40.5% |
$28.41M -8.3% |
$30.98M +318.1% |
| Long-Term Debt | $11.29M +214.6% |
$3.59M -40.2% |
$6.00M | $0.00 -100.0% |
$4.31M -25.7% |
$5.80M |
| Stockholders Equity | $141.54M +7.7% |
$131.39M +15.4% |
$113.89M +17.3% |
$97.09M +2.4% |
$94.82M +16.1% |
$81.69M +141.0% |
| R&D Expense | $3.02M -1.7% |
$3.07M +10.3% |
$2.78M +3.2% |
$2.70M +27.8% |
$2.11M +94.8% |
$1.08M +27.7% |
| Operating Income | $22.95M +28.2% |
$17.90M +24.9% |
$14.33M +73.7% |
$8.25M -28.7% |
$11.58M -56.8% |
$26.78M +202.4% |
| Gross Profit | $155.46M +16.7% |
$133.20M +18.1% |
$112.78M +33.2% |
$84.68M +15.4% |
$73.41M -8.4% |
$80.11M +43.0% |
| Shares Outstanding | 38.02M -2.8% |
39.13M +1.6% |
38.51M +1.2% |
38.05M -4.0% |
39.64M +1.2% |
39.19M +3.2% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $71.91M | +24.0% | +14.0% |
| Net Income | September 30, 2025 | $3.51M | -9.4% | +11.3% |
| Diluted EPS | September 30, 2025 | $0.09 | -10.0% | +12.5% |
| Total Assets | September 30, 2025 | $202.36M | +19.4% | +9.6% |
| Cash and Equivalents | September 30, 2025 | $11.12M | -2.0% | -44.4% |
| Long-Term Debt | September 30, 2025 | $19.59M | +436.6% | +465.2% |
| Stockholders Equity | September 30, 2025 | $133.61M | +6.9% | -4.4% |
| R&D Expense | September 30, 2025 | $775.0K | +2.4% | -8.5% |
| Operating Income | September 30, 2025 | $5.64M | +0.2% | +10.7% |
| Gross Profit | September 30, 2025 | $41.34M | +20.3% | +12.6% |
| Shares Outstanding | September 30, 2025 | 38.02M | -2.3% | -4.0% |
- VIEMED HEALTHCARE, INC. reported Total Revenue of $270.28 million for fiscal year 2025.
- VIEMED HEALTHCARE, INC. showed an increase of +20.5% in Total Revenue compared to the prior fiscal year.
- VIEMED HEALTHCARE, INC. reported Net Income of $14.93 million for fiscal year 2025.
- VIEMED HEALTHCARE, INC. showed an increase of +32.6% in Net Income compared to the prior fiscal year.
- VIEMED HEALTHCARE, INC. reported Diluted EPS of $0.37 per share for fiscal year 2025.
- VIEMED HEALTHCARE, INC. showed an increase of +32.1% in Diluted EPS compared to the prior fiscal year.
- VIEMED HEALTHCARE, INC. reported Total Assets of $199.15 million for fiscal year 2025.
- VIEMED HEALTHCARE, INC. showed an increase of +12.5% in Total Assets compared to the prior fiscal year.
- VIEMED HEALTHCARE, INC. reported Cash and Equivalents of $13.50 million for fiscal year 2025.
- VIEMED HEALTHCARE, INC. showed a decrease of -23.0% in Cash and Equivalents compared to the prior fiscal year.
- VIEMED HEALTHCARE, INC. reported Long-Term Debt of $11.29 million for fiscal year 2025.
- VIEMED HEALTHCARE, INC. showed an increase of +214.6% in Long-Term Debt compared to the prior fiscal year.
- VIEMED HEALTHCARE, INC. reported Stockholders Equity of $141.54 million for fiscal year 2025.
- VIEMED HEALTHCARE, INC. showed an increase of +7.7% in Stockholders Equity compared to the prior fiscal year.
- VIEMED HEALTHCARE, INC. reported R&D Expense of $3.02 million for fiscal year 2025.
- VIEMED HEALTHCARE, INC. showed a decrease of -1.7% in R&D Expense compared to the prior fiscal year.
- VIEMED HEALTHCARE, INC. reported Operating Income of $22.95 million for fiscal year 2025.
- VIEMED HEALTHCARE, INC. showed an increase of +28.2% in Operating Income compared to the prior fiscal year.
- VIEMED HEALTHCARE, INC. reported Gross Profit of $155.46 million for fiscal year 2025.
- VIEMED HEALTHCARE, INC. showed an increase of +16.7% in Gross Profit compared to the prior fiscal year.
- VIEMED HEALTHCARE, INC. reported Shares Outstanding of 38.02 million shares for fiscal year 2025.
- VIEMED HEALTHCARE, INC. showed a decrease of -2.8% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: